Evidence map›Paper›PMID 29444683›Full record

ArticleLipids in health and disease2018

Potential effects of the combination of nicotinamide, vitamin B2 and vitamin C on oxidative-mediated hepatotoxicity induced by thioacetamide.

Samir A E Bashandy, Hossam Ebaid, Sherif A Abdelmottaleb Moussa, Ibrahim M Alhazza, Iftekhar Hassan, Abdulaziz Alaamer, Jameel Al Tamimi

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Propionic acid secreted byLife metabolism · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Vitamin B combination reduces fluconazole toxicity in Wistar rats.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Samir A E BashandyPharmacology Department, Medical Division, National Research Centre, Bohouth St. (former EL Tahrir St.), Dokki, Giza, EL, 33, Egypt.
Hossam EbaidDepartment of Zoology, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia. hossamebaid@yahoo.com.
Sherif A Abdelmottaleb MoussaCommittee of Radiation and Environmental Pollution Protection (CREPP), Department of Physics, College of Science, Al- Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Ibrahim M AlhazzaDepartment of Zoology, Faculty of Science, Minia University, Minia, Egypt.
Iftekhar HassanDepartment of Zoology, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia.
Abdulaziz AlaamerCommittee of Radiation and Environmental Pollution Protection (CREPP), Department of Physics, College of Science, Al- Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Jameel Al TamimiPharmacology Department, Medical Division, National Research Centre, Bohouth St. (former EL Tahrir St.), Dokki, Giza, EL, 33, Egypt.
Imam Mohammad ibn Saud Islamic University · SAKing Saud University · SANational Research Centre · EGMinia University · EG

Funding

Deanship of Scientific Research at King Saud University RG-1436-004
6 · The paper itself

Abstract

backgroundThe liver disease is one of the most important traditional public health problems in Egypt. Oxidative stress is attributed to such pathological condition that further contributes to the initiation and progression of liver injury. In the present study, we have investigated if the strong antioxidant power of Nicotinamide (NA), Vitamin B2 (VB2), and Vitamin C (VC) can ameliorate TAA-induced oxidative stress-mediated liver injury in the rats.

methodsThirty-six albino rats were divided into six groups: Control group; TAA group (IP injection with TAA at a dosage of 200 mg/Kg three times a week for two months); TAA + NA group (rats administered with NA at a dosage of 200 mg/kg daily besides TAA as in the control); TAA + VB2 group (rats administered with vitamin B2 at a dosage of 30 mg/kg daily besides injection with TAA); TAA + VC group (rats administered with vitamin C at a dosage of 200 mg/kg daily along with injection of TAA). TAA + NA + VB + VC group (rats administered the with the three vitamins daily in TAA pre-injected at the respective doses described above).

resultsTreatment of rats with TAA led to a significant elevation of aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), lactate dehydrogenase (LDH), total bilirubin, cholesterol, triglycerides, low-density lipoprotein (LDL) and tumor necrosis factor-alpha (TNF-α) in the serum samples. Moreover, malondialdehyde (MDA), hydroxyproline and nitic oxide (NO) were also significantly increased in the TAA-treated rats, while reduced glutathione (GSH), superoxide dismutase (SOD) and catalase (CAT) were significantly compromised in the hepatic samples. Rats administered with NA, VB2, and VC as individually or in combination ameliorated the deleterious effects of TAA that was confirmed by histopathology. However, the combination of the three vitamins was found more effective as compared to each of the vitamins.

conclusionOur work demonstrates that NA, VB2, and VC cross-talk with each other that act as a more potent biochemical chain of antioxidant defense against TAA-induced toxicities in vivo.

Indexed as

AnimalsAntioxidantsAscorbic AcidChemical and Drug Induced Liver InjuryDrug CombinationsHumansLiverNiacinamideOxidative StressRatsRiboflavinThioacetamideAntioxidantsAscorbic AcidDrug CombinationsNiacinamideRiboflavinThioacetamideHepatotoxicityInflammatory markersLipid profileNicotinamideOxidative stressThioacetamideVitamin B2Vitamin C

Identifiers

PMID29444683
PMCPMC5813429
OpenAlexW2793934290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.